CTLA-4 Blockade During Dendritic Cell Based Booster Vaccination Influences Dendritic Cell Survival and CTL Expansion

Journal of Immune Based Therapies and Vaccines
doi 10.1186/1476-8518-5-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dendritic Cell Vaccination and Immune Monitoring

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2008English

Human Dendritic Cell Subsets for Vaccination

Journal of Clinical Immunology
AllergyImmunology
2005English

Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

Journal of Immunology
AllergyImmunology
2001English

Dendritic Cell-Based Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

Dendritic Cell Vaccination, Immune Regulation, and Clinical Outcomes in Ovarian Cancer

Frontiers in Immunology
AllergyImmunology
2013English

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Dendritic Cell-Based Immunotherapy for Prostate Cancer

CA - A Cancer Journal for Clinicians
OncologyHematology
1999English

Follicular Dendritic Cell Sarcoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2017English

P13: Progesterone Regulates Dendritic Cell Function and Metabolism During Pregnancy

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy